US2012148683A1PendingUtilityA1

Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc

Assignee: ESCHMANN KLAUSPriority: May 12, 2009Filed: May 6, 2010Published: Jun 14, 2012
Est. expiryMay 12, 2029(~2.8 yrs left)· nominal 20-yr term from priority
A61P 3/10A61P 37/08A61P 9/10A61P 37/02A61P 37/00A61P 37/06A61P 9/00A61P 31/10A61P 31/12A61P 35/00A61P 31/04A61P 27/06A61P 25/00A61P 31/18A61P 27/02A61P 33/00A61P 29/00A61P 1/02A61P 11/00A61P 11/06A61P 21/00A61P 19/00A61P 19/10A61P 1/00A61P 13/12A61P 19/02A61P 11/02A61P 17/04A61P 17/06A61P 1/16A61P 17/00A61P 1/04A61K 45/06A61K 33/30A61K 33/04A61K 36/73Y02A50/30
33
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

It pertains to a composition which comprises a combination of Aronia extract in an amount of at least about 10 μg/mg and seleniumin in an amount from about 0.0001 μg/mg to about 2.0 μg/mg. The composition may further comprise zinc as additional micronutrient. The composition may be formulated as a pharmaceutical or a nutraceutical composition.

Claims

exact text as granted — not AI-modified
1 . A composition comprising  Aronia  extract in an amount of at least about 10 μg/mg and selenium in an amount of from about 0.0001 μg/mg to about 2.0 μg/mg. 
     
     
         2 . The composition according to  claim 1 , further comprising additional zinc. 
     
     
         3 . The composition according to  claim 2 , comprising zinc in a concentration from about 0.0001 mg/mg to about 0.5 mg/mg. 
     
     
         4 . The composition according to any one of the preceding  claim 1 , wherein the composition further comprises at least one pharmaceutically or nutraceutically acceptable excipient or a mixture thereof. 
     
     
         5 . The composition according to  claim 4 , wherein the composition is formulated as a pharmaceutical composition. 
     
     
         6 . The composition according to  claim 5  formulated for peroral/oral, buccal, sublingual, mucosal or topical administration. 
     
     
         7 . The composition according to  claim 4 , wherein the composition is formulated as a nutraceutical or supplementary neutraceutical composition. 
     
     
         8 . The composition according to  claim 7 , designed as an ingestible solution or suspension, comprising an active ingredient in dissolved or suspended form, or as a solid administration form, or added as a food supplement to daily food products. 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . The composition according to  claim 8 , wherein the solid administration form is in the form of tablets, capsules, or dragees 
     
     
         14 . A method of preparing a medicament comprising:
 mixing the composition of  claim 1  with one or more suitable pharmaceutically excipient(s).   
     
     
         15 . A method of treating inflammatory diseases or conditions, bacterial infections, fungal infections, viral infections, parasitic infections and combinations thereof, the method comprising:
 administering an effective amount of the composition of  claim 1  to a subject in need thereof.   
     
     
         16 . The method according to  claim 15 , wherein the inflammatory disease or condition is associated with one or more selected from the group consisting of autoimmune diseases, inflammatory bowel disease, inflammatory diseases of eye, multiple sclerosis, scleroderma, and graft-versus-host disease. 
     
     
         17 . The method according to  claim 15 , wherein the inflammatory disease is selected form the group consisting of Crohn's disease, colitis, osteo- and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, adult Still's disease, uveitis, Wegener's granulomatosis, Behcet disease, Sjoegren's syndrome, sarcoidosis, and conjunctivitis.

Join the waitlist — get patent alerts

Track US2012148683A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.